[{"id":"f514461c-de65-4d4b-ac81-de9f774794d1","acronym":"","url":"https://clinicaltrials.gov/study/NCT04625205","created_at":"2021-01-19T20:35:22.976Z","updated_at":"2025-02-25T16:26:10.622Z","phase":"Phase 1","brief_title":"A Clinical Study of the Safety and Activity of the Investigational Cell Therapy NEO-PTC-01 in Patients With Advanced Melanoma","source_id_and_acronym":"NCT04625205","lead_sponsor":"BioNTech US Inc.","biomarkers":" BRAF","pipe":" | ","alterations":" BRAF mutation","tags":["BRAF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRAF mutation"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BNT221"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 22","initiation":"Initiation: 12/01/2020","start_date":" 12/01/2020","primary_txt":" Primary completion: 12/01/2029","primary_completion_date":" 12/01/2029","study_txt":" Completion: 12/01/2029","study_completion_date":" 12/01/2029","last_update_posted":"2024-12-19"}]